Works by Chang, Te-Sheng


Results: 78
    1
    2

    Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 1, p. 252, doi. 10.3390/v15010252
    By:
    • Hsieh, Yung-Yu;
    • Chen, Wei-Ming;
    • Chang, Kao-Chi;
    • Chang, Te-Sheng;
    • Hung, Chao-Hung;
    • Yang, Yao-Hsu;
    • Tung, Shui-Yi;
    • Wei, Kuo-Liang;
    • Shen, Chen-Heng;
    • Wu, Cheng-Shyong;
    • Ding, Yuan-Jie;
    • Hu, Jing-Hong;
    • Huang, Yu-Ting;
    • Lin, Meng-Hung;
    • Lu, Chung-Kuang;
    • Lin, Yi-Hsiung;
    • Lin, Ming-Shyan
    Publication type:
    Article
    3
    4
    5

    Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 2, p. 333, doi. 10.3390/v14020333
    By:
    • Chen, Yen-Chun;
    • Chang, Te-Sheng;
    • Chen, Chien-Hung;
    • Cheng, Pin-Nan;
    • Lo, Ching-Chu;
    • Mo, Lein-Ray;
    • Chen, Chun-Ting;
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Huang, Yi-Hsiang;
    • Tai, Chi-Ming;
    • Peng, Cheng-Yuan;
    • Bair, Ming-Jong;
    • Yeh, Ming-Lun;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Lee, Pei-Lun;
    • Chong, Lee-Won;
    • Hung, Chao-Hung;
    • Huang, Jee-Fu
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.575667
    By:
    • Wei, Kuo-Liang;
    • Chou, Jian-Liang;
    • Chen, Yin-Chen;
    • Low, Jie-Ting;
    • Lin, Guan-Ling;
    • Liu, Jing-Lan;
    • Chang, Te-Sheng;
    • Chen, Wei-Ming;
    • Hsieh, Yung-Yu;
    • Yan, Pearlly S.;
    • Chuang, Yu-Ming;
    • Lin, Jora M. J.;
    • Wu, Shu-Fen;
    • Chiang, Ming-Ko;
    • Li, Chin;
    • Wu, Cheng-Shyong;
    • Chan, Michael W. Y.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Real‐world efficacy and safety of universal 8‐week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre‐end‐stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

    Published in:
    Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 2, p. 1, doi. 10.1002/kjm2.12929
    By:
    • Wang, Szu‐Jen;
    • Huang, Chung‐Feng;
    • Chang, Te‐Sheng;
    • Lo, Ching‐Chu;
    • Hung, Chao‐Hung;
    • Huang, Chien‐Wei;
    • Chong, Lee‐Won;
    • Cheng, Pin‐Nan;
    • Yeh, Ming‐Lun;
    • Peng, Cheng‐Yuan;
    • Cheng, Chien‐Yu;
    • Huang, Jee‐Fu;
    • Bair, Ming‐Jong;
    • Lin, Chih‐Lang;
    • Yang, Chi‐Chieh;
    • Kuo, Hsing‐Tao;
    • Hsieh, Tsai‐Yuan;
    • Lee, Tzong‐Hsi;
    • Lee, Pei‐Lun;
    • Wu, Wen‐Chih
    Publication type:
    Article
    36
    37

    Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.

    Published in:
    Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1199, doi. 10.1007/s40121-024-00968-5
    By:
    • Yang, Chun-Chi;
    • Huang, Chung-Feng;
    • Chang, Te-Sheng;
    • Lo, Ching-Chu;
    • Hung, Chao-Hung;
    • Huang, Chien-Wei;
    • Chong, Lee-Won;
    • Cheng, Pin-Nan;
    • Yeh, Ming-Lun;
    • Peng, Cheng-Yuan;
    • Cheng, Chien-Yu;
    • Huang, Jee-Fu;
    • Bair, Ming-Jong;
    • Lin, Chih-Lang;
    • Yang, Chi-Chieh;
    • Wang, Szu-Jen;
    • Hsieh, Tsai-Yuan;
    • Lee, Tzong-Hsi;
    • Lee, Pei-Lun;
    • Wu, Wen-Chih
    Publication type:
    Article
    38

    Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.

    Published in:
    Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 485, doi. 10.1007/s40121-021-00576-7
    By:
    • Cheng, Pin-Nan;
    • Mo, Lein-Ray;
    • Chen, Chun-Ting;
    • Chen, Chi-Yi;
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Lo, Ching-Chu;
    • Tseng, Kuo-Chih;
    • Huang, Yi-Hsiang;
    • Tai, Chi-Ming;
    • Peng, Cheng-Yuan;
    • Bair, Ming-Jong;
    • Chen, Chien-Hung;
    • Yeh, Ming-Lun;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Lee, Pei-Lun;
    • Chong, Lee-Won;
    • Hung, Chao-Hung;
    • Chang, Te Sheng
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50